Response to TNF inhibitors does not differ according to smoking status in a study of patients with axial spondyloarthritis (axSpA). However smokers and ex-smokers start from a different baseline of disease severity than never smokers. The study of 627 patients from the British Society for Rheumatology Biologics Register for Ankylosing Spondylitis commencing on their first ...
Smoking is no excuse not to give biologics in AS
By Mardi Chapman
5 Mar 2019